Startups
Translating scientific discoveries into affordable, globally accessible public health solutions
Overview
Location
United States, New York
Employees
201-500
Founded date
1996
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 19, 2024 | Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate | A large Phase 3 trial will evaluate whether the M72/AS01E vaccine candidate can protect adolescents and adults from pulmonary tuberculosis Clinical trial site at University of the Witwatersrand, Johannesburg, South Africa, is first of up to... |
| Feb 1, 2024 | Penta Teams Up with IAVI & Achilles Vaccines to Develop New Treatments for HIV, Emerging Infections & Neglected Diseases | We are excited to be working with IAVI and Achilles to leverage our expertise and bring about real change for patients around the world.” — Carlo Giaquinto, Penta Foundation PresidentPADOVA, VENETO, ITALY, February 1, 2024 /EINPresswire.com... |
| Jun 8, 2023 | Encouraging First-in-Human Results for a Promising HIV Vaccine | Cross-posted from: NIH Director’s Blog Posted on June 6th, 2023 by Lawrence Tabak, D.D.S., Ph.D. Researchers used a customized nanoparticle (top left) to learn more about guiding the immune system to mount a desired robust response, the typ... |
| May 22, 2023 | Digital health news, funding round up in the prior week; May 22, 2023 | BetterUp partnered with Carahsoft; HippocraticAI raised $50M; CVS shuts down clinical trial business Top Health News Steer Health, an AI-driven Automation & Growth Platform, announced the launch of its self-service patient platform for ... |
| May 3, 2023 | FDA approves first RSV vaccine to protect older adults | Older Americans this fall could get an RSV vaccine for the first time, after the Food and Drug Administration approved Wednesday a new shot from drugmaker GSK to guard against a virus that leads to thousands of hospitalizations and deaths i... |
| Apr 7, 2022 | IAVI and Moderna Partner to Tackle Broad Global Health Priorities Using mRNA for Vaccines and Antibodies | Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis NEW YORK, NY and CAMBRIDGE, MA / ACCESSWIRE / April 7, 2022 / Moderna, Inc., (NASDAQ:MRNA) a biotechnology ... |
| Apr 24, 2021 | Moderna's mRNA technology could help in the decades-long search for an HIV vaccine | Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida, on August 13, 2020. Photo by CHANDAN KHANNA/AFP via Getty Images Moderna's mRNA tech could change... |
| Apr 19, 2021 | Moderna’s mRNA technology could help in the decades-long search for an HIV vaccine | Biotechnology company Moderna protocol files for COVID-19 vaccinations are kept at the Research Centers of America in Hollywood, Florida, on August 13, 2020. Photo by CHANDAN KHANNA/AFP via Getty Images Moderna’s mRNA tech could change the ... |
| Jan 25, 2021 | Merck drops out of the Covid-19 vaccine race after subpar data | “We are grateful to our collaborators who worked with us on these vaccine candidates and to the volunteers in the trials,” said Dr. Dean Y. Li, president of Merck Research Laboratories, in a news release. “We are resolute in our commitment ... |
Show more
Reviews 0
FAQ about IAVI
When was IAVI founded?
IAVI was founded in 1996.
What has the press written about IAVI?
Parsers VC has collected 17 articles mentioning IAVI, among them “Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate” (Mar 19, 2024) and “Penta Teams Up with IAVI & Achilles Vaccines to Develop New Treatments for HIV, Emerging Infections & Neglected Diseases” (Feb 1, 2024).
Is IAVI still active?
Yes, IAVI is active; its latest activity on Parsers VC dates from Jun 1, 2026.